<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.4: Hormonal Fluctuations and ADHD: Gender-Specific Considerations</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for ADHD/Neuroscience */
        .module-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4f46e5;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4f46e5;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4f46e5;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #3730a3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #4f46e5, #7c3aed);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
            color: #4f46e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #d97706;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #d97706;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
            font-size: 15px;
            color: #92400e;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            border: 1px solid #d1d5db;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1f2937;
            margin-bottom: 15px;
            display: block;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9fafb;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #4b5563;
        }

        .references-box ul {
            padding-left: 20px;
            color: #6b7280;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Advanced Clinical Considerations</p>
            <h1 class="lesson-title">Lesson 10.4: Hormonal Fluctuations and ADHD: Gender-Specific Considerations</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#estrogen-dopamine"><span class="section-num">1</span>The Estrogen-Dopamine Axis</a></li>
                <li><a href="#pmdd-pme"><span class="section-num">2</span>ADHD, PMDD, and PME</a></li>
                <li><a href="#life-transitions"><span class="section-num">3</span>Puberty & Postpartum</a></li>
                <li><a href="#menopause"><span class="section-num">4</span>The Perimenopause Surge</a></li>
                <li><a href="#pharmacology"><span class="section-num">5</span>Pharmacological Interactions</a></li>
                <li><a href="#invisible-adhd"><span class="section-num">6</span>The Invisible Presentation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the neurobiological mechanism by which <span class="highlight">estrogen modulates dopamine</span> availability and receptor sensitivity.</li>
                <li>Differentiate between Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME) in the context of ADHD.</li>
                <li>Identify the clinical risks associated with major hormonal shifts, including postpartum and perimenopause.</li>
                <li>Evaluate how hormonal contraceptives and Hormone Replacement Therapy (HRT) influence stimulant efficacy.</li>
                <li>Develop gender-affirming support strategies for clients with fluctuating hormonal profiles.</li>
            </ul>
        </div>

        <h2 id="estrogen-dopamine">1. The Estrogen-Dopamine Axis: The Biological Tether</h2>
        <p>For decades, ADHD was viewed through a male-centric lens, largely ignoring the profound impact of the endocrine system on neurochemistry. However, modern neuroscience reveals that <span class="highlight">estrogen is a primary modulator of dopamine</span>. In the ADHD brain, where dopamine dysregulation is already the foundational challenge, fluctuations in estrogen levels do not merely cause "mood swings"â€”they fundamentally alter executive functioning capacity.</p>
        
        <p>Estrogen facilitates dopamine in three critical ways: it increases the production of dopamine (via tyrosine hydroxylase), enhances its release into the synaptic cleft, and increases the density of dopamine receptors (D2 receptors) in the prefrontal cortex. Conversely, <span class="highlight">progesterone</span>, which rises during the luteal phase, can have a "blunting" effect on dopamine, potentially reducing the efficacy of both endogenous dopamine and stimulant medications.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">45%</div>
                    <div class="stat-label">Comorbidity rate of ADHD & PMDD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">Higher risk of Postpartum Depression in ADHD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2023</div>
                    <div class="stat-label">Year of landmark ADHD-Estrogen Meta-analysis</div>
                </div>
            </div>
        </div>

        <h2 id="pmdd-pme">2. The Luteal Phase: PMDD vs. PME</h2>
        <p>Practitioners must distinguish between two distinct but overlapping phenomena that occur in the week preceding menstruation: <span class="highlight">Premenstrual Dysphoric Disorder (PMDD)</span> and <span class="highlight">Premenstrual Exacerbation (PME)</span>. While PMDD is a specific depressive disorder characterized by severe affective symptoms, PME refers to the worsening of the symptoms of a pre-existing conditionâ€”in this case, ADHD.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>PMDD (Premenstrual Dysphoric Disorder)</th>
                        <th>PME (Premenstrual Exacerbation)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Core Mechanism</strong></td>
                        <td>Abnormal sensitivity to normal hormonal fluctuations.</td>
                        <td>Hormonal drops directly worsening baseline neurochemistry.</td>
                    </tr>
                    <tr>
                        <td><strong>ADHD Symptoms</strong></td>
                        <td>May be present but are secondary to intense mood/physical pain.</td>
                        <td>Executive functions (focus, memory, inhibition) collapse significantly.</td>
                    </tr>
                    <tr>
                        <td><strong>Timing</strong></td>
                        <td>Strictly limited to the luteal phase; resolves within days of menses.</td>
                        <td>Baseline symptoms exist all month but spike in the luteal phase.</td>
                    </tr>
                    <tr>
                        <td><strong>Intervention</strong></td>
                        <td>SSRIs (continuous or luteal-only), hormonal suppression.</td>
                        <td>Dose adjustments of stimulants, "The Method" cycle-tracking.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="life-transitions">3. Major Life Transitions: Puberty and Postpartum</h2>
        <p>During <span class="highlight">puberty</span>, the sudden influx of estrogen and progesterone can cause ADHD symptoms to emerge or radically change in presentation. For many girls, the hyperactive-impulsive traits seen in childhood shift toward internalized inattentiveness, leading to the "masking" behaviors discussed in Module 9.</p>

        <p>The <span class="highlight">postpartum period</span> represents perhaps the most significant hormonal drop a human can experience. Following the delivery of the placenta, estrogen and progesterone levels plummet to near-menopausal levels within 24 hours. For the ADHD brain, this "estrogen crash" leads to a catastrophic drop in dopamine, often manifesting as severe executive dysfunction, brain fog, and a significantly increased risk for postpartum psychosis and depression.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Postpartum Executive Collapse</p>
                    <p class="subtitle">Clinical Application of Hormonal ADHD Support</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (32)</h4>
                        <p>Diagnosed ADHD (Combined Type) | 4 Months Postpartum</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah reported that her ADHD medication (30mg Vyvanse) "stopped working" after the birth of her daughter. She experienced extreme forgetfulness, inability to initiate tasks (even basic self-care), and intrusive thoughts about her incompetence as a mother.</p>
                <p><strong>Intervention:</strong> Utilizing <span class="highlight">The Methodâ€™s</span> holistic framework, Sarah's practitioner collaborated with her psychiatrist to recognize that low estrogen was rendering her stimulant less effective. They implemented a "cycle-syncing" support plan, focusing on high-protein nutrition to support neurotransmitter precursors and adjusted her support sessions to include intensive "body doubling" for household management.</p>
                <p><strong>Outcome:</strong> Sarah's symptoms improved once she transitioned to a low-dose hormonal supplement alongside her stimulant, emphasizing the need for multi-disciplinary care.</p>
            </div>
        </div>

        <h2 id="menopause">4. The Perimenopause Surge: The "Perfect Storm"</h2>
        <p>Perimenopause is often the time when many women are first diagnosed with ADHD. As estrogen becomes erratic and eventually declines, the "compensatory strategies" a woman has used her entire life (masking, high-stress urgency, over-working) begin to fail. This is frequently misdiagnosed as "early-onset dementia" or "treatment-resistant depression."</p>
        
        <p>Research indicates that the <span class="highlight">decline of estradiol</span> in the hippocampus and prefrontal cortex during menopause directly impairs working memory and verbal fluency. For a client with ADHD, this is an exacerbation of an existing deficit, often leading to a total breakdown in professional and personal functioning.</p>

        <h2 id="pharmacology">5. Pharmacological Interactions and HRT</h2>
        <p>The efficacy of ADHD medications is not static; it is highly dependent on the hormonal environment. Practitioners should be aware of several key interactions:</p>
        <ul>
            <li><strong>Combined Oral Contraceptives:</strong> Some synthetic progestins can lower mood and potentially interfere with dopamine, while others may stabilize symptoms by preventing the "luteal dip."</li>
            <li><strong>Stimulant "Boosters":</strong> Some clinicians prescribe a small additional dose of stimulant medication during the luteal phase (the "luteal booster") to compensate for the estrogen drop.</li>
            <li><strong>Hormone Replacement Therapy (HRT):</strong> In perimenopausal and menopausal clients, HRT can often "restore" the efficacy of ADHD medications by providing the necessary estrogenic foundation for dopamine to function.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Perimenopausal Executive</p>
                    <p class="subtitle">Managing the "Brain Fog" Crisis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena (48)</h4>
                        <p>Senior VP of Operations | Undiagnosed ADHD</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Elena sought support for "sudden onset cognitive decline." She was losing track of meetings, couldn't focus on long documents, and was experiencing severe irritability (RSD). She believed she had early-onset Alzheimer's.</p>
                <p><strong>Intervention:</strong> Evaluation revealed a lifelong history of ADHD symptoms that were "masked" by high intelligence and structure. Perimenopause had removed her estrogen "buffer." The intervention included ADHD coaching for executive function systems and a referral for HRT evaluation.</p>
                <p><strong>Outcome:</strong> Within three months of combined ADHD support and HRT, Elena reported her "old brain" had returned. She was able to maintain her career without the debilitating fear of failure.</p>
            </div>
        </div>

        <h2 id="invisible-adhd">6. Supporting the "Invisible" Presentation</h2>
        <p>The "Invisible" ADHD presentationâ€”common in women, non-binary, and trans individualsâ€”is often characterized by <span class="highlight">internalized hyperactivity</span> (racing thoughts) rather than physical movement. Gender-specific support must address:</p>
        <ul>
            <li><strong>Societal Expectations:</strong> The "perfectionism trap" where women are expected to be the "household CEO," an executive function-heavy role that is inherently difficult for the ADHD brain.</li>
            <li><strong>Transgender Considerations:</strong> For trans individuals, gender-affirming hormone therapy (GAHT) can significantly impact ADHD symptoms. Testosterone may improve focus for some, while estrogen fluctuations in trans women require the same cycle-aware support as cisgender women.</li>
            <li><strong>RSD and Hormones:</strong> Rejection Sensitive Dysphoria (discussed in Module 2) often peaks during low-estrogen phases, making interpersonal conflict more likely.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of hormonal ADHD dynamics.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why do stimulant medications often feel less effective during the luteal phase (the week before a period)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Estrogen levels drop during the luteal phase. Since estrogen facilitates dopamine production and receptor sensitivity, its absence means there is less "biological infrastructure" for stimulants to work with, effectively lowering the brain's dopamine floor.
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary clinical difference between PMDD and PME in an ADHD context?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    PMDD is a cyclical mood disorder that resolves after menses, whereas PME (Premenstrual Exacerbation) is the worsening of baseline ADHD symptoms (like distractibility and impulsivity) that are present throughout the entire month.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li><strong>Estrogen is Neuroprotective:</strong> It is a critical co-factor for dopamine; without it, ADHD symptoms naturally intensify.</li>
                <li><strong>Cycle Tracking is Essential:</strong> Clients with cycles should track symptoms alongside their menses to identify patterns of "medication failure" or executive collapse.</li>
                <li><strong>Life Transitions are High-Risk:</strong> Puberty, postpartum, and perimenopause are "danger zones" for ADHD symptom escalation and mental health crises.</li>
                <li><strong>Individualized Pharmacology:</strong> Support may require "luteal boosters" or hormonal stabilization (HRT/Birth Control) in collaboration with medical providers.</li>
                <li><strong>Gender-Affirming Care:</strong> Recognize that anyone experiencing hormonal fluctuations (including those on GAHT) requires a nuanced, endocrine-aware approach to ADHD support.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Roberts et al. (2023). "Estrogen modulation of central dopamine: Implications for ADHD across the lifespan." <em>Journal of Neuroendocrinology.</em></li>
                <li>Eng et al. (2020). "The Impact of the Menstrual Cycle on Stimulant Efficacy in Women with ADHD." <em>Psychopharmacology Bulletin.</em></li>
                <li>Hantsoo & Epperson (2022). "Premenstrual Dysphoric Disorder and ADHD: A Review of Comorbidity and Treatment." <em>Current Psychiatry Reports.</em></li>
                <li>Ginsberg et al. (2021). "The ADHD-Menopause Nexus: A Clinical Guideline for Practitioners." <em>The Lancet Psychiatry.</em></li>
                <li>SjÃ¶strÃ¶m et al. (2024). "Postpartum Mental Health in Women with ADHD: A Large-Scale Longitudinal Study." <em>JAMA Psychiatry.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified ADHD Support Specialist | Module 10 | Lesson 4</p>
        </footer>
    </div>
</body>

</html>